Literature DB >> 10438827

High-fidelity correction of mutations at multiple chromosomal positions by adeno-associated virus vectors.

N Inoue1, R K Hirata, D W Russell.   

Abstract

The gene targeting techniques used to modify chromosomes in mouse embryonic stem cells have had limited success with many other cell types, especially normal primary cells with restricted growth capacity outside the organism. This is due in large part to the technical problems and/or inefficiency of conventional DNA transfer methods, as well as the low rates of homologous recombination obtained in unselected cell populations. We recently described an alternative approach in which adeno-associated virus (AAV) vectors were used to modify homologous chromosomal sequences, and targeting rates close to 1% were observed at the single copy hypoxanthine phosphoribosyl transferase (HPRT) locus in normal human cells (D. W. Russell and R. K. Hirata, Nat. Genet. 18:325-330, 1998). Here we report experiments in which we used a retroviral shuttle vector system to introduce and characterize target loci in human chromosomes, and demonstrate that AAV vectors can correct several types of mutations with high fidelity, independent of chromosomal position. The gene targeting rates varied depending on the type of mutation being corrected, implicating cellular mismatch recognition functions in the reaction. Since AAV vectors can efficiently deliver DNA to many cell types both in vivo and ex vivo, our results suggest that AAV-mediated gene targeting will have wide applicability, including therapeutic gene correction.

Entities:  

Mesh:

Year:  1999        PMID: 10438827      PMCID: PMC104264     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  19 in total

1.  Adeno-associated virus vector integration junctions.

Authors:  E A Rutledge; D W Russell
Journal:  J Virol       Date:  1997-11       Impact factor: 5.103

Review 2.  Therapeutic gene targeting.

Authors:  R J Yáñez; A C Porter
Journal:  Gene Ther       Date:  1998-02       Impact factor: 5.250

3.  Cellular recombination pathways and viral terminal repeat hairpin structures are sufficient for adeno-associated virus integration in vivo and in vitro.

Authors:  C C Yang; X Xiao; X Zhu; D C Ansardi; N D Epstein; M R Frey; A G Matera; R J Samulski
Journal:  J Virol       Date:  1997-12       Impact factor: 5.103

4.  Distribution of targets for avian retrovirus DNA integration in vivo.

Authors:  E S Withers-Ward; Y Kitamura; J P Barnes; J M Coffin
Journal:  Genes Dev       Date:  1994-06-15       Impact factor: 11.361

5.  Rapid detection of homologous recombinants in nontransformed human cells.

Authors:  S R Williams; F C Ousley; L J Vitez; R B DuBridge
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

6.  Functional genomics in mice by tagged sequence mutagenesis.

Authors:  G G Hicks; E G Shi; X M Li; C H Li; M Pawlak; H E Ruley
Journal:  Nat Genet       Date:  1997-08       Impact factor: 38.330

7.  Bypass of senescence after disruption of p21CIP1/WAF1 gene in normal diploid human fibroblasts.

Authors:  J P Brown; W Wei; J M Sedivy
Journal:  Science       Date:  1997-08-08       Impact factor: 47.728

8.  Human gene targeting by viral vectors.

Authors:  D W Russell; R K Hirata
Journal:  Nat Genet       Date:  1998-04       Impact factor: 38.330

9.  Packaging cells based on inducible gene amplification for the production of adeno-associated virus vectors.

Authors:  N Inoue; D W Russell
Journal:  J Virol       Date:  1998-09       Impact factor: 5.103

10.  Recombinant adeno-associated virus-mediated high-efficiency, transient expression of the murine cationic amino acid transporter (ecotropic retroviral receptor) permits stable transduction of human HeLa cells by ecotropic retroviral vectors.

Authors:  J Bertran; J L Miller; Y Yang; A Fenimore-Justman; F Rueda; E F Vanin; A W Nienhuis
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

View more
  26 in total

1.  Involvement of cellular double-stranded DNA break binding proteins in processing of the recombinant adeno-associated virus genome.

Authors:  L Zentilin; A Marcello; M Giacca
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

2.  Efficient gene targeting mediated by adeno-associated virus and DNA double-strand breaks.

Authors:  Matthew H Porteus; Toni Cathomen; Matthew D Weitzman; David Baltimore
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

Review 3.  Recombinant adeno-associated virus transduction and integration.

Authors:  Brian R Schultz; Jeffrey S Chamberlain
Journal:  Mol Ther       Date:  2008-05-20       Impact factor: 11.454

4.  Chromosomal position effects on AAV-mediated gene targeting.

Authors:  Anda M Cornea; David W Russell
Journal:  Nucleic Acids Res       Date:  2010-02-25       Impact factor: 16.971

5.  Design and packaging of adeno-associated virus gene targeting vectors.

Authors:  R K Hirata; D W Russell
Journal:  J Virol       Date:  2000-05       Impact factor: 5.103

6.  An experimental system for the evaluation of retroviral vector design to diminish the risk for proto-oncogene activation.

Authors:  Byoung Y Ryu; Marguerite V Evans-Galea; John T Gray; David M Bodine; Derek A Persons; Arthur W Nienhuis
Journal:  Blood       Date:  2007-11-08       Impact factor: 22.113

7.  Gene targeting of mutant COL1A2 alleles in mesenchymal stem cells from individuals with osteogenesis imperfecta.

Authors:  Joel R Chamberlain; David R Deyle; Ulrike Schwarze; Peirong Wang; Roli K Hirata; Yi Li; Peter H Byers; David W Russell
Journal:  Mol Ther       Date:  2007-10-23       Impact factor: 11.454

8.  A comparison of synthetic oligodeoxynucleotides, DNA fragments and AAV-1 for targeted episomal and chromosomal gene repair.

Authors:  Xavier Leclerc; Olivier Danos; Daniel Scherman; Antoine Kichler
Journal:  BMC Biotechnol       Date:  2009-04-20       Impact factor: 2.563

9.  Human gene targeting by adeno-associated virus vectors is enhanced by DNA double-strand breaks.

Authors:  Daniel G Miller; Lisa M Petek; David W Russell
Journal:  Mol Cell Biol       Date:  2003-05       Impact factor: 4.272

10.  Human gene targeting favors insertions over deletions.

Authors:  David W Russell; Roli K Hirata
Journal:  Hum Gene Ther       Date:  2008-09       Impact factor: 5.695

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.